The Current Role of Osteoclast Inhibitors in Patients with Prostate Cancer
Purpose.Prostate cancer (PCa) is one of the most frequently diagnosed malignancies worldwide.Hormonal deprivation therapy is a well-established treatment for locally advanced or metastatic diseases but exposes patients to the risk of osteoporosis and fragility fractures.Furthermore, the tropism of the PCa cells to osseous metastases increases the i